Concepedia
Statistics
Publications
7
Citations
273
H-Index
Active since
2007
Affiliations
Assistance Publique – Hôpitaux de Paris(Current)
Sorbonne Université
Université Claude Bernard Lyon 1
Hôpital Bichat-Claude-Bernard
Hôpital Saint-Antoine
Chloé Tesmoingt is an author at Assistance Publique – Hôpitaux de Paris specializing in medicine, oncology, and pharmacotherapy.
Publications per year
2007–2022
Gemcitabine plus oxaliplatin (GEMOX) combined with cetuximab in patients with progressive advanced stage hepatocellular carcinoma
Amani Asnacios, Olivier Romano, Chloé Tesmoingt et al. · Cancer · 2008 · 138 citations
Medicine, Oncology, Pharmacology +17
Enzyme therapy in Fabry disease: severe adverse events associated with anti‐agalsidase cross‐reactive IgG antibodies
Chloé Tesmoingt, Olivier Lidove, Axele Reberga et al. · British Journal of Clinical Pharmacology · 2009 · 32 citations · Full text
Life Sciences, Immunology, Internal Medicine +17
Medication Reconciliation: A Prospective Study in an Internal Medicine Unit
Laura Andréoli, Jean‐François Alexandra, Chloé Tesmoingt et al. · Drugs & Aging · 2014 · 26 citations
Pharmacy, Internal Medicine, Pharmacy Practice +10
Gemcitabine, oxaliplatin (GEMOX) and cetuximab for treatment of hepatocellular carcinoma (HCC): Results of the phase II study ERGO
Sami Louafi, Mohamed Hebbar, Olivier Rosmorduc et al. · Journal of Clinical Oncology · 2007 · 23 citations
Glucocorticoids with low-dose anti-IL1 anakinra rescue in severe non-ICU COVID-19 infection: A cohort study
Raphaël Borie, Laurent Savale, Antoine Dossier et al. · PLoS ONE · 2020 · 21 citations · Full text
Medicine, Immunology, Pharmacotherapy +17
1–5 of 7